The Skinny on Skin – John M. Newsam, Author, and CEO of Tioga Research – Research and Development of Formulations for the Skin
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 29 May 2020
⏱️ 34 minutes
🧾️ Download transcript
Summary
John M. Newsam, author, and CEO of Tioga Research, discusses skin in general, care for skin, and his work at Tioga Research.
Podcast Points:
- An overview of transdermal drug delivery
- Active versus inactive ingredients
- Do enzymes break down proteins? — a focus on skin and products for the skin
Newsam has provided his expertise in scientific and strategic consulting to multiple US Fortune500 companies, as well as early-phase biotech and materials companies around the globe, including the US, UK, and Korea. He has worked with notable government institutions such as IFP Energies Nouvelles, and he has been a respected member of many academic advisory committees.
Newsam provides an overview of Tioga Research, their objectives in research, and overall mission. As he states, they are heavily involved in research and early development of formulations applied to the skin, including pharmaceutical (primary) as well as the beauty/skin care area as well.
Newsam explains how 'active' ingredients are diffused into the skin in order to achieve the desired therapeutic benefit, and he talks about transdermal delivery of drugs, and why this method can be particularly useful.
The research CEO provides an overview of active and inactive ingredients, and FDA-approved products. As he states, cocktails of molecules tend to work best for delivering the benefits to users. Newsam explains how they have worked to assemble a long list of safe compounds and mixtures, and databases of useful excipients (inactive substances).
Continuing, Newsam delivers an overview of what manufacturers can claim regarding their products and the benefits they may provide. As he states, in theory, any claim of benefit should be supported by a scientific study, but the cosmetic industry is so large, with so many products on the market, it can be difficult to police every product that exists.
Additionally, Newsam talks about other drugs, permeability, and how enzymes can degrade proteins. Newsam is a materials chemist by training, and he has authored in excess of 170 scientific publications.
Visit these links to find out more about John M. Newsam:
https://www.linkedin.com/in/jnewsam/
https://www.researchgate.net/profile/John_Newsam
https://scholar.google.com/citations?user=1fk9pdIAAAAJ&hl=en
https://profiles.ucsd.edu/john.newsam
https://en.wikipedia.org/wiki/John_M._Newsam
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Forget frequently asked questions. |
| 0:02.0 | Common sense, common knowledge, or Google. |
| 0:05.0 | How about advice from a real genius? |
| 0:07.0 | 95% of people in any profession are good enough to be qualified and licensed. |
| 0:11.0 | 5% go above and beyond. They become very good at what they do, but only 0.1% are real Jesus. |
| 0:18.0 | Richard Jacobs has made it his life's mission to find them for you. He hunts down and interviews geniuses in every field, sleep science, |
| 0:25.7 | cancer, stem cells, ketogenic diets, and more. Here come the geniuses. This is the Finding Genius |
| 0:32.1 | podcast that Richard Jacobs. This is the Finding Genius Podcast. |
| 0:33.0 | That is Richard Jacobs. |
| 0:35.0 | Hello, this is Richard Jacobs with the Finding Genius Podcast. |
| 0:41.0 | I guess today is the CEO of Tioga research. |
| 0:44.6 | His name is John Newsom. |
| 0:46.3 | We're going to talk about the skin structure of the properties |
| 0:50.0 | and the work that Tioga is doing. |
| 0:52.3 | So, John, thanks for coming. |
| 0:54.1 | Thanks, Rich. |
| 0:55.0 | Delighted to contribute and look forward |
| 0:58.0 | to the interview with you. |
| 1:00.3 | Yeah, if you would tell me about Tioga, |
| 1:01.8 | what's the premise for the company? |
| 1:03.0 | Tioga Research is a contract research organization, a CRO, and we're dedicated to doing research and early development of formulations applied to the skin. |
| 1:18.5 | So that is predominantly pharmaceutical formulations, but we also work in the beauty care, cosmetic, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.